351 related articles for article (PubMed ID: 27900619)
41. Direct renin inhibition: extricating facts from façades.
Juncos L
Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):153-67. PubMed ID: 23487045
[TBL] [Abstract][Full Text] [Related]
42. Anti-hypertensive peptides released from milk proteins by probiotics.
Ahtesh FB; Stojanovska L; Apostolopoulos V
Maturitas; 2018 Sep; 115():103-109. PubMed ID: 30049341
[TBL] [Abstract][Full Text] [Related]
43. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
[TBL] [Abstract][Full Text] [Related]
44. Salt, the renin-angiotensin-aldosterone system and resistant hypertension.
Shimosawa T
Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of renin: an updated review of the development of renin inhibitors.
Li YC
Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
[TBL] [Abstract][Full Text] [Related]
46. Aliskiren, the first direct renin inhibitor for treatment of hypertension: the path of its development.
Jadhav M; Yeola C; Zope G; Nabar A
J Postgrad Med; 2012; 58(1):32-8. PubMed ID: 22387646
[TBL] [Abstract][Full Text] [Related]
47. New drug targets for hypertension: A literature review.
Gao Q; Xu L; Cai J
Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166037. PubMed ID: 33309796
[TBL] [Abstract][Full Text] [Related]
48. Blood pressure in renal disease: how to accomplish the goal?
Robles NR; Hernandez-Gallego R
Cardiovasc Ther; 2012 Aug; 30(4):193-8. PubMed ID: 22759229
[TBL] [Abstract][Full Text] [Related]
49. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
Coca A; Giner V
Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
[TBL] [Abstract][Full Text] [Related]
50. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
Laragh JH; Sealey JE
Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070
[TBL] [Abstract][Full Text] [Related]
51. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Weir MR
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
[TBL] [Abstract][Full Text] [Related]
52. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
Lazich I; Bakris GL
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
[TBL] [Abstract][Full Text] [Related]
53. Antihypertensive Effects of Probiotics.
Robles-Vera I; Toral M; Romero M; Jiménez R; Sánchez M; Pérez-Vizcaíno F; Duarte J
Curr Hypertens Rep; 2017 Apr; 19(4):26. PubMed ID: 28315049
[TBL] [Abstract][Full Text] [Related]
54. Blockage of the renin-angiotensin system in the secondary prevention of stroke: beneficial effects beyond blood pressure reduction?
Castilla-Guerra L; del Carmen Fernández-Moreno M; Jiménez-Hernandez MD
Stroke; 2009 Mar; 40(3):e75; author reply e76. PubMed ID: 19182077
[No Abstract] [Full Text] [Related]
55. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
[TBL] [Abstract][Full Text] [Related]
56. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
Drapala A; Sikora M; Ufnal M
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
58. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
Rust P; Ekmekcioglu C
Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
[TBL] [Abstract][Full Text] [Related]
59. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
60. Management of nocturnal hypertension.
Vij R; Peixoto AJ
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):607-18. PubMed ID: 19505276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
